Volume 4, Issue 3 (Multidisciplinary Cancer Investigation 2020)                   Multidiscip Cancer Investig 2020, 4(3): 38-40 | Back to browse issues page


XML Print


Download citation:
BibTeX | RIS | EndNote | Medlars | ProCite | Reference Manager | RefWorks
Send citation to:

Hirri F, Khalil M A I, Bajwa M S A, Afzal N. CyberKnife Ablation of a Solitary Para-Aortic Lymph Node Metastasis After Robotic-Assisted Radical Prostatectomy. Multidiscip Cancer Investig 2020; 4 (3) :38-40
URL: http://mcijournal.com/article-1-280-en.html
1- Dorset County Hospital NHS Foundation Trust , faithhirri@gmail.com
2- Dorset County Hospital NHS Foundation Trust
Abstract:   (2809 Views)
Introduction: Radical prostatectomy is an effective curative treatment option for organ-confined prostate cancer. There is a recent trend in offering curative treatment to patients with oligometastatic disease. More sensitive imaging modalities can identify oligometastatic disease that is not usually detected by conventional imaging techniques.
Case presentation: We present a case in which a solitary left para-aortic metastatic lesion was ablated; using CyberKnife image-guided stereotactic radiotherapy after robotic-assisted radical prostatectomy with negative margins and negative lymph node status.
Conclusion: With the increasing number of patients diagnosed with oligometastatic prostate cancer, there is a paradigm shift towards its treatment with curative intent. The unusual sites of metastasis, can be cured effectively with Cyber Knife technology, whilst minimising adverse effects. Our report is an effort to highlight this technique as an effective treatment modality to be used and popularised as a standard option.
Full-Text [PDF 284 kb]   (1784 Downloads)    
Select article type: Case Report and Series | Subject: Health Services, Quality of Life and Outcomes
Received: 2020/04/30 | Accepted: 2020/06/11 | ePublished: 2020/07/1

Add your comments about this article : Your username or Email:
CAPTCHA

Send email to the article author


Rights and permissions
Creative Commons License This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.

© 2024 CC BY-NC 4.0 | Multidisciplinary Cancer Investigation

Designed & Developed by : Yektaweb